ESR1 and breast cancer: SOX2 has been identified as a target of miR-140, and in ER-α breast cancer cells, estrogen stimulation lowers miR-140 expression through ER-α binding to an ERE flanking the mir-140 promoter, thus increasing levels of SOX2 [141].